|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 366.29 USD | -1.42% |
|
+0.80% | +11.91% |
| 16/07 | Merck gets US FDA nod for first-in-its-class oral cholesterol drug | RE |
| 13/07 | BofA Securities Adjusts Amgen Price Target to $312 From $307 | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AMGEN INC. | Other Pharmaceuticals | -1.42% | +0.80% | +11.91% | +24.27% | +47.72% | 20TCr |  |  | |
- Stock Market
- Stocks
- AMGN Stock
- Charts Amgen Inc.
- Comparison Chart
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
